囊性肾肿块影像学当代进展:组织病理学对照及患者管理重点
本文更新综述囊性肾肿块影像学。多数偶然发现的囊性肾肿块为良性,影像可确诊且无需随访。高密度肿块(20-70 HU)为不确定性,可先用超声、再用多期CT或MRI进一步检查,因多数为出血/蛋白性囊肿。Bosniak标准仍是诊断和分类的参考标准,但组织病理学分类和管理已演变,导致非根治性管理或监测增加,包括Bosniak 3病变。
要点
- 多数偶然发现的囊性肾肿块为良性,影像可确诊且无需随访。
- 平扫或单期增强CT测得20-70 HU的高密度肿块为不确定性,多数为出血/蛋白性囊肿。
- Bosniak标准仍是诊断和分类的参考标准,但组织病理学分类和管理已演变。
核心结论
- 囊性肾肿块影像学更新:多数偶然发现的囊性肾肿块为良性,影像可确诊且无需随访;Bosniak标准仍是参考标准,但组织病理学分类和管理已演变,导致非根治性管理或监测增加,包括Bosniak 3病变。
研究设计与样本
- 本文为囊性肾肿块影像学的更新综述,未报告系统检索范围、纳入文献数量或证据分级。
关键影像表现/征象
- 平扫或单期增强CT测得20-70 HU的高密度肿块为不确定性,多数为出血/蛋白性囊肿(HPCs)。
- 双能CT可能通过抑制常规CT观察到的伪强化来改善HPCs与肿块的鉴别。
- 平扫CT>70 HU或T1加权成像信号明显增高时可确诊HPCs。
- 多房囊性肾细胞癌(RCC)已重新分类为低恶性潜能囊性肾肿瘤,少数Bosniak 2F囊性肿块随访期间出现影像学进展。
- 以囊性成分为主的RCC侵袭性低于实性RCC,Bosniak III囊性肿块行为非侵袭性;管状囊性RCC影像特征独特,类似胰腺浆液性微囊腺瘤;混合上皮间质肿瘤(MEST)现归入囊性肾瘤谱系,伴上皮囊肿的血管平滑肌脂肪瘤(AMLEC)类似含囊性成分的乏脂性AML。
诊断标准与关键数值
- Bosniak标准仍是囊性肾肿块诊断和分类的参考标准。
- 平扫CT>70 HU或T1加权成像信号明显增高可确诊出血/蛋白性囊肿(HPCs)。
- 平扫或单期增强CT测得20-70 HU的高密度肿块为不确定性,可先用超声、再用多期CT或MRI进一步检查。
临床应用与阅片要点
- 多数偶然发现的囊性肾肿块为良性,影像可确诊且无需随访。
- 平扫或单期增强CT测得20-70 HU的高密度肿块为不确定性,可先用超声、再用多期CT或MRI进一步检查,因多数为出血/蛋白性囊肿。
- 双能CT可能改善出血/蛋白性囊肿与肿块的鉴别。
- 组织病理学分类和管理已演变,导致非根治性管理或监测增加,包括Bosniak 3病变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This article presents an updated review of cystic renal mass imaging. Most cystic renal masses encountered incidentally are benign and can be diagnosed confidently on imaging and require no follow-up. Hyperattenuating masses discovered at unenhanced or single-phase enhanced computed tomography (CT) measuring between 20-70 HU are indeterminate and can be further investigated first by using ultrasound and, then with multi-phase CT or magnetic resonance imaging (MRI); as the majority represent haemorrhagic/proteinaceous cysts (HPCs). Dual-energy CT may improve differentiation between HPCs and masses by suppressing unwanted pseudo-enhancement observed with conventional CT. HPCs can be diagnosed confidently when measuring >70 HU at unenhanced CT or showing markedly increased signal on T1-weighted imaging. Although the Bosniak criteria remains the reference standard for diagnosis and classification of cystic renal masses, histopathological classification and current management has evolved: multilocular cystic renal cell carcinoma (RCC) has been reclassified as a cystic renal neoplasm of low malignant potential, few Bosniak 2F cystic masses progress radiologically during follow-up; RCC with predominantly cystic components are less aggressive than solid RCC; and Bosniak III cystic masses behave non-aggressively. These advances have led to an increase in non-radical management or surveillance of cystic renal masses including Bosniak 3 lesions. Tubulocystic RCC is a newly described entity with distinct imaging characteristics, resembling a pancreatic serous microcystadenoma. Other benign cystic masses including: mixed epithelial stromal tumours (MEST) are now considered in the spectrum of cystic nephroma and angiomyolipoma (AML) with epithelial cysts (AMLEC) resemble a fat-poor AML with cystic components.
引用
- Narayanasamy S, Krishna S, Prasad Shanbhogue AK, et al. Contemporary update on imaging of cystic renal masses with histopathological correlation and emphasis on patient management. Clin Radiol. 2018. PMID: 30314810. doi:10.1016/j.crad.2018.09.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。